Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 18,400 shares at $66.85 ($1.2M) on 2019-04-01, disclosed to the SEC on 2019-04-03.
Open-market sale of $1.2M AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.03 | 5,854 | $387K | 31.6% |
| 2 | $66.03 | 5,854 | $387K | 31.6% |
| 3 | $66.85 | 2,546 | $170K | 13.9% |
| 4 | $66.85 | 2,546 | $170K | 13.9% |
| 5 | $68.09 | 1,500 | $102K | 8.4% |
| 6 | $68.72 | 100 |
| $7K |
| 0.6% |
| Total | $66.44 avg | 18,400 | $1.2M | 100% |
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |